FindTrial
Sign In

GREENLIGHT LASER FOR BPH – A PROSPECTIVE INTERNATIONAL STUDY ON INDICATIONS AND OUTCOMES.

GREENLIGHT LASER FOR BPH – A PROSPECTIVE INTERNATIONAL STUDY ON INDICATIONS AND OUTCOMES.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26977
Enrollment
2000
Registered
2010-04-07
Start date
2010-04-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment

Interventions

None listed

Sponsors

Clinical Research Office of the Endourological Society (CROES) Clinical Research Office of the Endourological Society Academic Medical Center University of Amsterdam Department of Urology (G4-162) Meibergdreef 9 1105 AZ AMSTERDAM ZO The Netherlands P: +31205666377 F: +31205669585
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion for a one year period of patients treated by greenlight laser or TURP.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
To assess the current indications for HPS greenlight laser treatment and the treatment outcomes in terms of objective and subjective improvement.—

Secondary

MeasureTime frame
1. To assess the peri-operative morbidity (30 days) by using the Clavien system; 2. To define risk factors for the development of peri-operative morbidity after HPS greenlight laser treatment.—

Contacts

Public ContactSonja Rees Vellinga, van
info@croesoffice.org+31 (0)20 56 66377

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)